bioAffinity Technologies, Inc. (BIAFW)

NASDAQ: BIAFW · Real-Time Price · USD · Warrants
0.0700
0.00 (0.00%)
Aug 29, 2025, 4:00 PM - Market closed
Market Cap6.96M
Revenue (ttm)7.68M
Net Income (ttm)-11.69M
Shares Out 28.19M
EPS (ttm)-0.69
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Close0.0700
Day's Rangen/a
52-Week Range0.0525 - 2.4900
Beta2.55
Analystsn/a
Price Targetn/a
Earnings DateMar 28, 2025

About BIAFW

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person’s sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have... [Read more]

Sector Healthcare
Founded 2014
Employees 57
Stock Exchange NASDAQ
Ticker Symbol BIAFW
Full Company Profile

News

There is no news available yet.